Company intelligence / Profile preview
Fenix Holding
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
Overview
Fenix Pharma is an Italian specialty pharmaceutical company that was acquired by the Spanish healthcare group Uriach in July 2023. Founded in 2011 by a group of experienced pharmaceutical managers, the company specializes in the development and commercialization of products in the fields of urology, gynecology, osteoarticular health, and pediatrics. Its portfolio includes a mix of branded off-patent medicines, medical devices, and high-end nutraceuticals. Fenix Pharma is recognized for its strong commercial presence in the Italian market and its cooperative-based origins, which fostered a lean and efficient business model. The acquisition by Uriach aims to strengthen the group's position in the Italian consumer healthcare market.
- Therapeutic areas
- CardiovascularRheumatologyNeurologyInfectious Diseases
- Modalities
- Small moleculeMedical deviceNutraceutical
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Fenix Holding.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fenix Holding.